Search
Home › Stocks › AZN › News
1 / 10 Next
Regulatory
06 Feb 07:00 - US FDA grants Fasenra Orphan Drug Designation
05 Feb 07:05 - US FDA grants Breakthrough Therapy Designation
05 Feb 07:00 - EMA grants PRIME eligibility for MEDI8897
01 Feb 15:00 - Total Voting Rights
01 Feb 13:17 - Forxiga receives positive EU CHMP opinion
25 Jan 14:00 - Completion of divestment of US Synagis rights
07 Jan 13:00 - AstraZeneca announces organisational changes
02 Jan 15:00 - Total Voting Rights
20 Dec 13:47 - Bevespi Aerosphere approved in the EU for COPD
20 Dec 07:05 - Lynparza meets primary endpoint in SOLO-3 trial
20 Dec 07:00 - Phase III ROCKIES and OLYMPUS roxadustat trials
19 Dec 18:31 - FDA approves Lynparza as 1L maintenance therapy
18 Dec 09:09 - Roxadustat approved in China for the treatment of
14 Dec 07:00 - Directorate Change
07 Dec 07:00 - Update on the Phase III EAGLE trial of Imfinzi
06 Dec 07:00 - Divestment of rights to Covis completed
04 Dec 15:00 - Director/PDMR Shareholding
03 Dec 16:00 - Total Voting Rights
03 Dec 16:00 - Block listing Interim Review
03 Dec 07:00 - Grünenthal Agreement for Nexium, Vimovo Completed